In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury.
Lagiakos HR, Zou Y, Igawa H, Therrien E, Lawrenz M, Kato M, Svensson M, Gray F, Jensen K, Dahlgren MK, Pelletier RD, Dingley K, Bell JA, Liu Z, Jiang Y, Zhou H, Skene RJ, Nie Z.
Lagiakos HR, et al. Among authors: bell ja.
J Med Chem. 2024 Dec 13. doi: 10.1021/acs.jmedchem.4c02074. Online ahead of print.
J Med Chem. 2024.
PMID: 39670820